Literature DB >> 16368290

The effects of periodontal therapy on vascular endothelial function: a pilot trial.

John R Elter1, Alan L Hinderliter, Steven Offenbacher, James D Beck, Melissa Caughey, Nadine Brodala, Phoebus N Madianos.   

Abstract

BACKGROUND: Chronic periodontal infection is associated with an increased risk of coronary heart disease. Although the mechanism responsible for the relationship between periodontal disease and cardiovascular events is not fully understood, it is hypothesized that the chronic inflammatory burden of periodontal disease may lead to impaired functioning of the vascular endothelium.
METHODS: Twenty-two otherwise healthy adults with moderate to severe periodontitis who underwent complete mouth disinfection were evaluated to determine if periodontal therapy would result in improved endothelial function and a decrease in serum inflammatory markers. Subjects had measurements of periodontal disease severity, flow-mediated (endothelium-dependent), and nitroglycerin-mediated (endothelium-independent) dilation of the brachial artery, serum C-reactive protein (CRP) and interleukin 6 (IL-6), and serum total and high-density lipoprotein cholesterol levels on 2 baseline visits separated by 1 month and, again, 1 month after treatment.
RESULTS: There were no significant changes in clinical periodontal measures, flow-mediated dilation, nitroglycerin-mediated dilation, CRP, IL-6, total cholesterol, or high-density lipoprotein cholesterol between the repeated baseline measurements. Periodontal treatment, however, resulted in significant improvements in periodontal pocketing, flow-mediated dilation, and serum IL-6, as well as a trend toward reduction in serum CRP; there were no significant changes in nitroglycerin-mediated dilation or in cholesterol levels.
CONCLUSIONS: These results represent proof of concept that improvement in endothelial function, as measured by flow-mediated dilation of the brachial artery, may be possible through near-elimination of chronic oral infection and suggest that the conduct of a larger controlled trial is justified.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16368290     DOI: 10.1016/j.ahj.2005.10.002

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  40 in total

1.  Periodontal therapy alters gene expression of peripheral blood monocytes.

Authors:  Panos N Papapanou; Michael H Sedaghatfar; Ryan T Demmer; Dana L Wolf; Jun Yang; Georg A Roth; Romanita Celenti; Paul B Belusko; Evanthia Lalla; Paul Pavlidis
Journal:  J Clin Periodontol       Date:  2007-09       Impact factor: 8.728

2.  [Effects of non-surgical periodontal therapy on serum inflammatory markers and metabolic level in obese rats].

Authors:  Su-Lan Zhong; Jia Ni; Qiao-Xue Chai; Lei Chen; Jin-Cai Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-06-20

3.  Periodontal disease in chronic kidney disease and end-stage renal disease patients: a review.

Authors:  Venkatesh K Ariyamuthu; Karl D Nolph; Bruce E Ringdahl
Journal:  Cardiorenal Med       Date:  2013-04       Impact factor: 2.041

4.  Lipoproteins and lipoprotein metabolism in periodontal disease.

Authors:  Rachel Griffiths; Suzanne Barbour
Journal:  Clin Lipidol       Date:  2010-06

5.  Evaluation of serum anti-cardiolipin antibodies after non-surgical periodontal treatment in chronic periodontitis patients.

Authors:  Farin Kiany; Azita Hedayati
Journal:  Odontology       Date:  2014-02-14       Impact factor: 2.634

6.  Serum inflammatory mediators in pregnancy: changes after periodontal treatment and association with pregnancy outcomes.

Authors:  Bryan S Michalowicz; M John Novak; James S Hodges; Anthony DiAngelis; William Buchanan; Panos N Papapanou; Dennis A Mitchell; James E Ferguson; Virginia Lupo; James Bofill; Stephen Matseoane; Michelle Steffen; Jeffrey L Ebersole
Journal:  J Periodontol       Date:  2009-11       Impact factor: 6.993

7.  Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease.

Authors:  Steven Offenbacher; James D Beck; Kevin Moss; Luisito Mendoza; David W Paquette; David A Barrow; David J Couper; Dawn D Stewart; Karen L Falkner; Susan P Graham; Sara Grossi; John C Gunsolley; Theresa Madden; Gerardo Maupome; Maurizio Trevisan; Thomas E Van Dyke; Robert J Genco
Journal:  J Periodontol       Date:  2009-02       Impact factor: 6.993

Review 8.  Poor oral health as a chronic, potentially modifiable dementia risk factor: review of the literature.

Authors:  James M Noble; Nikolaos Scarmeas; Panos N Papapanou
Journal:  Curr Neurol Neurosci Rep       Date:  2013-10       Impact factor: 5.081

Review 9.  Periodontal disease and risk of atherosclerotic coronary heart disease.

Authors:  Takako Nakajima; Kazuhisa Yamazaki
Journal:  Odontology       Date:  2009-07-29       Impact factor: 2.634

10.  Heterogeneity of systemic inflammatory responses to periodontal therapy.

Authors:  Jan H Behle; Michael H Sedaghatfar; Ryan T Demmer; Dana L Wolf; Romanita Celenti; Moritz Kebschull; Paul B Belusko; Miriam Herrera-Abreu; Evanthia Lalla; Panos N Papapanou
Journal:  J Clin Periodontol       Date:  2009-03-11       Impact factor: 8.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.